IVC Omega-3 Supplement With FDA Health Claim Premieres At PLMA
This article was originally published in The Tan Sheet
Executive Summary
IVC Industries is introducing a private label omega-3 supplement that will use FDA's qualified health claim addressing the association between omega-3 fatty acids and coronary heart disease.
You may also be interested in...
Pearson Plaintiffs Using Shortened Omega-3 Qualified Claim
Two of the Pearson plaintiffs plan to incorporate an abbreviated version of FDA's qualified health claim for omega-3 fatty acids and coronary heart disease on dietary supplement labeling.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands